CVS HEALTH CORP (CVS) Stock Earnings & Estimates
USA - NYSE:CVS - US1266501006 - Common Stock
80.26 USD
+0.39 (+0.49%)
81.08 USD
+0.82 (+1.02%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 322.467B 10.39% | 357.776B 10.95% | 372.809B 4.20% | 401.942B 7.81% | 418.697B 4.17% | 440.332B 5.17% | 470.997B 6.96% | 479.338B 1.77% | 483.513B 0.87% | 514.417B 6.39% | 546.789B 6.29% | |
| EBITDA YoY % growth | N/A 3.28% | N/A 0.50% | N/A -27.63% | 16.197B 9.80% | 18.147B 12.04% | 19.761B 8.89% | 21.966B 11.16% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 16.29B 6.95% | 15.086B -7.39% | 10.038B -33.46% | 13.998B 39.45% | 15.395B 9.98% | 16.341B 6.14% | 18.504B 13.24% | 18.775B 1.46% | N/A | N/A | N/A | |
| Operating Margin | 5.05% | 4.22% | 2.69% | 3.48% | 3.68% | 3.71% | 3.93% | 3.92% | N/A | N/A | N/A | |
| EPS YoY % growth | 8.70 3.45% | 8.74 0.46% | 5.42 -37.99% | 6.59 21.57% | 7.24 9.86% | 8.19 13.13% | 9.36 14.34% | 9.70 3.54% | 9.72 0.21% | 10.54 8.52% | 11.43 8.43% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.97 -18.41% | 2.38 5.93% | 2.02 11.46% | 1.69 5.91% | 1.21 24.59% | 2.72 14.27% | 2.35 16.48% | 1.89 11.56% | 1.26 4.22% |
| Revenue Q2Q % growth | 103.498B 5.92% | 100.851B 6.62% | 103.75B 4.89% | 104.285B 1.37% | 106.445B 2.85% | 104.671B 3.79% | 110.39B 6.40% | 110.837B 6.28% | 113.292B 6.43% |
| EBITDA Q2Q % growth | 3.033B 1.71% | 5.347B 23.52% | 5.049B 29.83% | 4.46B 16.72% | 3.52B 16.06% | 6.282B 17.49% | 5.435B 7.65% | 4.818B 8.03% | 3.827B 8.72% |
| EBIT Q2Q % growth | 2.429B -1.98% | 4.822B 42.92% | 4.223B 77.36% | 3.581B 42.22% | 2.573B 5.93% | 5.322B 10.37% | 4.637B 9.80% | 3.843B 7.32% | 2.761B 7.31% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 1.60 46.79% | 1.38 | 0.22 | 15.69% |
| Q2 2025 Q2Q % growth | 1.81 -1.09% | 1.47 | 0.34 | 22.99% |
| Q1 2025 Q2Q % growth | 2.25 71.76% | 1.72 | 0.53 | 30.76% |
| Q4 2024 Q2Q % growth | 1.19 -43.87% | 0.94 | 0.25 | 27.26% |
| Q3 2024 Q2Q % growth | 1.09 -50.68% | 1.52 | -0.43 | -28.40% |
| Q2 2024 Q2Q % growth | 1.83 -17.19% | 1.75 | 0.08 | 4.69% |
| Q1 2024 Q2Q % growth | 1.31 -40.45% | 1.71 | -0.40 | -23.44% |
| Q4 2023 Q2Q % growth | 2.12 6.53% | 2.01 | 0.11 | 5.45% |
| Q3 2023 Q2Q % growth | 2.21 5.74% | 2.16 | 0.05 | 2.51% |
| Q2 2023 Q2Q % growth | 2.21 -7.92% | 2.13 | 0.08 | 3.81% |
| Q1 2023 Q2Q % growth | 2.20 -0.90% | 2.11 | 0.09 | 4.28% |
| Q4 2022 Q2Q % growth | 1.99 0.51% | 1.94 | 0.05 | 2.46% |
| Q3 2022 Q2Q % growth | 2.09 6.09% | 2.01 | 0.08 | 3.87% |
| Q2 2022 Q2Q % growth | 2.40 -0.83% | 2.20 | 0.20 | 9.31% |
| Q1 2022 Q2Q % growth | 2.22 8.82% | 2.18 | 0.04 | 2.05% |
| Q4 2021 Q2Q % growth | 1.98 52.31% | 1.95 | 0.03 | 1.58% |
| Q3 2021 Q2Q % growth | 1.97 18.67% | 1.80 | 0.17 | 9.72% |
| Q2 2021 Q2Q % growth | 2.42 -8.33% | 2.08 | 0.34 | 16.07% |
| Q1 2021 Q2Q % growth | 2.04 6.81% | 1.73 | 0.31 | 17.77% |
| Q4 2020 Q2Q % growth | 1.30 -24.86% | 1.25 | 0.05 | 4.07% |
| Q3 2020 Q2Q % growth | 1.66 -9.78% | 1.34 | 0.32 | 23.54% |
| Q2 2020 Q2Q % growth | 2.64 39.68% | 1.95 | 0.69 | 35.54% |
| Q1 2020 Q2Q % growth | 1.91 17.90% | 1.64 | 0.27 | 16.24% |
| Q4 2019 Q2Q % growth | 1.73 | 1.70 | 0.03 | 1.78% |
| Q3 2019 Q2Q % growth | 1.84 | 1.79 | 0.05 | 2.99% |
| Q2 2019 Q2Q % growth | 1.89 | 1.71 | 0.18 | 10.46% |
| Q1 2019 Q2Q % growth | 1.62 | 1.52 | 0.10 | 6.73% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 102.871B 7.80% | 99.838B | 3.033B | 3.04% |
| Q2 2025 Q2Q % growth | 98.915B 8.42% | 95.444B | 3.471B | 3.64% |
| Q1 2025 Q2Q % growth | 94.588B 6.96% | 94.572B | 16M | 0.02% |
| Q4 2024 Q2Q % growth | 97.71B 4.15% | 98.16B | -450M | -0.46% |
| Q3 2024 Q2Q % growth | 95.428B 6.31% | 93.674B | 1.754B | 1.87% |
| Q2 2024 Q2Q % growth | 91.234B 2.60% | 92.411B | -1.177B | -1.27% |
| Q1 2024 Q2Q % growth | 88.437B 3.70% | 90.101B | -1.664B | -1.85% |
| Q4 2023 Q2Q % growth | 93.813B 11.89% | 91.309B | 2.504B | 2.74% |
| Q3 2023 Q2Q % growth | 89.764B 10.60% | 89.137B | 627M | 0.70% |
| Q2 2023 Q2Q % growth | 88.921B 10.27% | 87.398B | 1.523B | 1.74% |
| Q1 2023 Q2Q % growth | 85.278B 11.00% | 81.622B | 3.656B | 4.48% |
| Q4 2022 Q2Q % growth | 83.846B 9.45% | 76.971B | 6.875B | 8.93% |
| Q3 2022 Q2Q % growth | 81.159B 9.98% | 77.519B | 3.64B | 4.70% |
| Q2 2022 Q2Q % growth | 80.636B 11.04% | 77.133B | 3.503B | 4.54% |
| Q1 2022 Q2Q % growth | 76.826B 11.19% | 76.146B | 680M | 0.89% |
| Q4 2021 Q2Q % growth | 76.604B 10.14% | 76.428B | 176M | 0.23% |
| Q3 2021 Q2Q % growth | 73.794B 10.05% | 71.19B | 2.604B | 3.66% |
| Q2 2021 Q2Q % growth | 72.616B 11.13% | 71.002B | 1.614B | 2.27% |
| Q1 2021 Q2Q % growth | 69.097B 3.51% | 69.071B | 26M | 0.04% |
| Q4 2020 Q2Q % growth | 69.554B 3.98% | 69.434B | 120M | 0.17% |
| Q3 2020 Q2Q % growth | 67.056B 3.47% | 67.329B | -273M | -0.41% |
| Q2 2020 Q2Q % growth | 65.341B 3.01% | 64.87B | 471M | 0.73% |
| Q1 2020 Q2Q % growth | 66.755B 8.29% | 64.74B | 2.015B | 3.11% |
| Q4 2019 Q2Q % growth | 66.889B | 64.61B | 2.279B | 3.53% |
| Q3 2019 Q2Q % growth | 64.81B | 63.617B | 1.193B | 1.88% |
| Q2 2019 Q2Q % growth | 63.431B | 63.277B | 154M | 0.24% |
| Q1 2019 Q2Q % growth | 61.646B | 60.995B | 651M | 1.07% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 2.19% | 0.26% | 2.51% | 6.36% |
| Revenue | 1.21% | 1.76% | 0.81% | 2.88% |